Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:administeredBy |
oral ingestion
|
| gptkbp:alternativeName |
gptkb:DOM
2,5-Dimethoxy-4-methylamphetamine |
| gptkbp:CASNumber |
15588-94-8
|
| gptkbp:effect |
euphoria
hallucinations altered perception of time |
| gptkbp:has_duration_of_action |
14-20 hours
|
| gptkbp:hasMolecularFormula |
C11H17NO2
|
| https://www.w3.org/2000/01/rdf-schema#label |
C11 207
|
| gptkbp:includes |
gptkb:PiHKAL
|
| gptkbp:is_classified_as |
Hallucinogen
amphetamine derivative |
| gptkbp:IUPACName |
1-(4-methyl-2,5-dimethoxyphenyl)propan-2-amine
|
| gptkbp:legalStatus |
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(US) gptkb:Class_A_(UK) |
| gptkbp:relatedTo |
gptkb:2C-B
gptkb:2C-D DOB |
| gptkbp:was_first_synthesized_by |
gptkb:Alexander_Shulgin
|
| gptkbp:bfsParent |
gptkb:JNR_Class_C11_steam_locomotive
gptkb:SL_Hamanasu |
| gptkbp:bfsLayer |
7
|